EGFR and breast carcinoma: More recent studies by Williams et al. in 2020, showed that HUNK promotes breast cancer metastasis by phosphorylating the epidermal growth factor receptor (EGFR) at threonine (T) 654, enhancing downstream signaling from the receptor [11].